GADD45GIP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.68565161828838E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.52909999998163E-06 |
Normal-vs-Stage2 |
8.212400E-04 |
Normal-vs-Stage3 |
9.11260000791003E-09 |
Normal-vs-Stage4 |
3.64389995954895E-09 |
Stage1-vs-Stage2 |
1.649770E-01 |
Stage1-vs-Stage3 |
8.121600E-02 |
Stage1-vs-Stage4 |
7.459400E-03 |
Stage2-vs-Stage3 |
8.843200E-01 |
Stage2-vs-Stage4 |
4.841600E-01 |
Stage3-vs-Stage4 |
2.467400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.26720897400901E-12 |
Normal-vs-AfricanAmerican |
1.39009999999828E-06 |
Normal-vs-Asian |
5.348800E-01 |
Caucasian-vs-AfricanAmerican |
7.955000E-03 |
Caucasian-vs-Asian |
5.384200E-01 |
AfricanAmerican-vs-Asian |
1.661150E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.61442037095139E-12 |
Normal-vs-Female |
8.90209994608426E-09 |
Male-vs-Female |
2.205600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.975700E-04 |
Normal-vs-Age(41-60Yrs) |
3.62410002008318E-09 |
Normal-vs-Age(61-80Yrs) |
1.00979999917428E-08 |
Normal-vs-Age(81-100Yrs) |
7.180900E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.974630E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.648000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.576200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.661600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.484750E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.895200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.739500E-02 |
Normal-vs-Grade 2 |
2.2761999999954E-05 |
Normal-vs-Grade 3 |
4.75309791525547E-11 |
Normal-vs-Grade 4 |
1.30880000170919E-08 |
Grade 1-vs-Grade 2 |
5.648000E-01 |
Grade 1-vs-Grade 3 |
1.393400E-01 |
Grade 1-vs-Grade 4 |
7.758900E-03 |
Grade 2-vs-Grade 3 |
1.322620E-01 |
Grade 2-vs-Grade 4 |
3.120500E-03 |
Grade 3-vs-Grade 4 |
3.882000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.176810E-04 |
Normal-vs-ccB subtype |
5.21140000042664E-07 |
ccA subtype-vs-ccB subtype |
5.260200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.55699999995862E-06 |
Normal-vs-N1 |
2.009800E-02 |
N0-vs-N1 |
6.692100E-02 |
|
|